VOLUNTARY ANNOUNCEMENT - UPDATE REGARDING
RECENT BUSINESS DEVELOPMENTS
| Announcements and Notices read more...
Sep 19, 2022
BeiGene Receives Positive CHMP Opinion for BRUKINSA® (zanubrutinib) for the Treatment of Adults with Marginal Zone Lymphoma
| RegularNews read more...
Sep 14, 2022
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION
| Announcements and Notices read more...
Sep 14, 2022
APPOINTMENT OF MEMBER OF COMPENSATION COMMITTEE
| Announcements and Notices read more...
Sep 12, 2022
Next Day Disclosure Return
| Next Day Disclosure Returns read more...
Sep 12, 2022
VOLUNTARY ANNOUNCEMENT - UPDATE REGARDING
RECENT BUSINESS DEVELOPMENTS
| Announcements and Notices read more...
Sep 10, 2022
BeiGene Announces Data Presentations at ESMO 2022 Including Late-Breaking Oral Presentation for Tislelizumab in First-Line Unresectable Hepatocellular Cancer
read more...
Sep 07, 2022
BeiGene to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
read more...
Sep 07, 2022
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
| Announcements and Notices read more...
Sep 05, 2022
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2022
| Monthly Returns read more...
Sep 02, 2022
GRANT OF SHARE OPTIONS
| Announcements and Notices read more...
Aug 31, 2022
Next Day Disclosure Return
| Next Day Disclosure Returns read more...
Aug 30, 2022
Next Day Disclosure Return
| Next Day Disclosure Returns read more...
Aug 30, 2022
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
| Announcements and Notices read more...
Aug 30, 2022
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
| Announcements and Notices read more...
Aug 26, 2022
INTERIM RESULTS ANNOUNCEMENT
FOR THE SIX MONTHS ENDED JUNE 30, 2022
| Announcements and Notices read more...
Aug 23, 2022
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
| Announcements and Notices read more...
Aug 23, 2022
VOLUNTARY ANNOUNCEMENT - UPDATE REGARDING RECENT BUSINESS DEVELOPMENTS
| Announcements and Notices read more...
Aug 23, 2022
BeiGene Announces Acceptance of 11th Regulatory Submission for PD-1 Inhibitor Tislelizumab in China
read more...
Aug 15, 2022
BeiGene Announces Strategic Alliance with Ontada to Improve U.S. Community Oncology Care
read more...
